HIGHLIGHTS
- who: Pregnant Women et al. from the Prenatal Diagnosis Center, Guizhou Provincial People`s Hospital, Guiyang, China have published the research work: A Three-Year Prospective Study Assessing the Application of Chromosomal Microarray Analysis in 576 High-Risk Pregnant Women, in the Journal: Evidence-Based Complementary and Alternative Medicine of 15/Oct/2022
- what: The aim of this study was to evaluate the application of CMA in the prenatal diagnosis of high-risk Method. This study has obtained informed consent from the women before screening and diagnosis and was approved by the hospital medical ethics . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.